heart failure
Conditions
Interventions
control group:The treatment of inotropic drugs was managed at the discretion of the attending physician according to clinical experience.
PiCCO group:The hemodynamic parameters were used to guide the treatment of inotropic drugs.
Sponsors
Shanghai East Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. age>=18 years old; 2. signed the informed consent; 3. patients diagnosed with heart failure.
Exclusion criteria
Exclusion criteria: 1. Extensive peripheral vascular disease; 2. Severe valve disease; 3. Patient treated with extracorporeal membrane oxygenation (ECMO); 4. Pregnant or lactating women; 5. Combined with mechanical complications of the heart.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Length and cost of hospitalization;Duration of instrument-assisted treatment during hospitalization;Duration of inotropes, diuretics, vasopressors, or vasodilators during hospitalization;Changes of parameters related to cardiac function;Complications such as hemorrhage, hematoma, embolism and infection; | — |
Countries
China
Contacts
Public ContactJieyun You
Shanghai East Hospital
Outcome results
None listed